Clinical utility of a Web-enabled risk-assessment and clinical decision support program.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26938783)

Published in Genet Med on March 03, 2016

Authors

Lori A Orlando1,2, R Ryanne Wu1,2, Rachel A Myers1,2, Adam Buchanan3, Vincent C Henrich4, Elizabeth R Hauser5, Geoffrey S Ginsburg1,2

Author Affiliations

1: Duke Center for Applied Genomics & Precision Medicine, Duke University, Durham, North Carolina, USA.
2: Duke Department of Medicine, Duke University, Durham, North Carolina, USA.
3: Genomic Medicine Institute, Geisinger Health System, Danville, Pennsylvania, USA.
4: Center for Biotechnology, Genomics, and Health Research, University of North Carolina-Greensboro, Greensboro, North Carolina, USA.
5: Center for Human Genomics, Department of Medicine, Duke University and Epidemiological Research and Information Center, Durham VA Medical Center, Durham, North Carolina, USA.

Articles cited by this

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform (2008) 71.12

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA (2006) 11.22

Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet (1990) 9.48

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med (2005) 5.24

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol (2002) 4.38

Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care (2012) 3.85

Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial. Ann Intern Med (2012) 3.57

Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50

Analysis of a trial randomised in clusters. BMJ (1998) 3.10

Family history-taking in community family practice: implications for genetic screening. Genet Med (2001) 2.75

National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health. Ann Intern Med (2009) 2.58

The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res (2014) 1.97

Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet (2004) 1.96

Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med (2014) 1.85

Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med (2000) 1.71

Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat (2012) 1.66

Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns (2007) 1.65

Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study. Cancer (2011) 1.47

Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med (2011) 1.38

Health Heritage© a web-based tool for the collection and assessment of family health history: initial user experience and analytic validity. Public Health Genomics (2010) 1.31

Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns. Am J Gastroenterol (2003) 1.20

Personalized medicine vs guideline-based medicine. JAMA (2013) 1.18

Protocol for implementation of family health history collection and decision support into primary care using a computerized family health history system. BMC Health Serv Res (2011) 1.18

Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial. Genet Med (2010) 1.12

Development and validation of a primary care-based family health history and decision support program (MeTree). N C Med J (2013) 1.07

Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J (2009) 1.04

Referral to cancer genetic counseling: are there stages of readiness? Am J Med Genet C Semin Med Genet (2006) 1.02

Formative evaluation of clinician experience with integrating family history-based clinical decision support into clinical practice. J Pers Med (2014) 0.99

Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial. BMC Fam Pract (2013) 0.91

Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand. Am J Med Genet C Semin Med Genet (2014) 0.87

Use of a patient-entered family health history tool with decision support in primary care: impact of identification of increased risk patients on genetic counseling attendance. J Genet Couns (2014) 0.86

Collection of family health history for assessment of chronic disease risk in primary care. N C Med J (2013) 0.83

Screening women for oral contraception: can family history identify inherited thrombophilias? Obstet Gynecol (2012) 0.82

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling? Int J Gynecol Cancer (2013) 0.81

Quality of family history collection with use of a patient facing family history assessment tool. BMC Fam Pract (2014) 0.80

Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system. Int J Gynecol Cancer (2014) 0.78

Family history tools for primary care are not ready yet to be implemented. A systematic review. Eur J Gen Pract (2013) 0.78

Providing patient education: impact on quantity and quality of family health history collection. Fam Cancer (2014) 0.78

Accuracy of ovarian and colon cancer risk assessments by U.S. physicians. J Gen Intern Med (2014) 0.77